Evidence map›Paper›PMID 28830369›Full record

ArticleBMC ophthalmology2017

Dislocation of a previously successful XEN glaucoma implant into the anterior chamber: a case report.

Nikolaos Dervenis, Athanasia Maria Mikropoulou, Panagiotis Dervenis, Amanda Lewis

Abstract readCase Reports
In one paragraph

Article in BMC ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. [Glaucoma surgery today].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2021
    Review
  9. Article
  10. Article
  11. XENClinical ophthalmology (Auckland, N.Z.) · 2020
    Review
  12. Article
  13. Article
  14. How to Rescue of the Dislocated XENJournal of current ophthalmology
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nikolaos DervenisSussex Eye Hospital, Brighton, UK. nikosdervenis@gmail.com.ORCID http://orcid.org/0000-0002-7269-2785
Athanasia Maria MikropoulouDepartment of Ophthalmology, University Hospital of Alexandroupolis, Alexandroupolis, Greece.
Panagiotis DervenisAristotle University of Thessaloniki, Thessaloniki, Greece.
Amanda LewisSussex Eye Hospital, Brighton, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundXEN glaucoma implant (XEN gel stent, Aquesys, Inc) is a new minimally invasive device approved for the treatment of glaucoma. CASE PRESENTATION: A 45 year old female was being followed and treated for primary open angle glaucoma in our tertiary referral center. Due to failure of medical treatment in controlling the glaucoma, surgery was offered to the patient. The XEN 45 μ-fistula implant was successfully placed in both eyes and adequate intraocular pressure control was achieved for 4 months. The left eye pressure then increased and the XEN implant was found in the anterior chamber. Topical intraocular pressure lowering therapy had to be re-initiated to achieve adequate pressure control.

conclusionWe describe a new potential complication of the XEN glaucoma implant.

Indexed as

Anterior ChamberEquipment FailureForeign-Body MigrationGlaucoma Drainage ImplantsFemaleGlaucoma, Open-AngleHumansMiddle AgedPostoperative ComplicationsGlaucomaMigsXEN implant

Identifiers

PMID28830369
PMCPMC5568059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.